From Genes to Pathways to Novel Drugs For Multiple Sclerosis

Preventing pressure ulcers with smart monitoring

MoVax develops oral vaccines. The vaccine survives the gastrointestinal tract because of bio-encapsulation the API inside microbial cells. Microalgae are a highly promising delivery platform for oral vaccines.

At Multiscreening, we developed a patented technology to introduce High Throughput Screening (HTS) for in vivostudies, allowing our customers to increase patent protected market sales by 4 months for each animal experimental series being performed.

Nanoporous MicroNeedle Arrays (npMNAs), integrated into a patch for drug delivery through the skin

MyMicroZoo™ is a company that offers microbiome analysis and web-based tools to gather meta-data (e.g. age, health-status, exercise logs, etc.) as service to the general public, allowing them to gain knowledge and understanding of their microbiota through an innovative platform.

Humanised muscle models for preclinical testing - Leading in compound selection for neuromuscular disorders.

NatInLab develops promising compounds to battle Alzheimer's disease. We expect the compounds to be curative and show minimal side effects.